A new medical technology expected to be on the market in 2027 is poised to help patients in middle America have greater access to heart transplants. Xvivo Perfusion, a leader in organ transplant ...
ANDOVER, Mass., Aug. 2, 2023 /PRNewswire/ -- TransMedics Group, Inc. (TMDX) ("TransMedics"), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung ...
The U.S. Food and Drug Administration (FDA) has granted Vascular Perfusion Solutions, Inc. (VPS) a Breakthrough Device Designation for its groundbreaking VP.S Encore™ oxygenated perfusion cardiac ...
The global perfusion systems market is largely fueled by the increasing prevalence of cardiovascular disorders and the growing number of cardiac surgeries performed worldwide. In addition, the rising ...
GOTHENBURG, SE / ACCESS Newswire / April 22, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, preliminary ...
The much-anticipated Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission tomography myocardial perfusion imaging agent for the detection of coronary artery disease, ...
TransMedics' Organ Care System is driving market share gains by displacing the standard cold storage method for organ preservation. The National OCS Program removes barriers to adoption and improves ...
Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today announced that it has completed the acquisition of Ohio Valley Perfusion Associates ("OVPA"), a regional provider of ...
When a transplant surgeon who was set to fly a donor heart to Loyola Medical Center in Maywood from out of state fell ill with COVID-19, the transplant program turned to so-called "heart-in-a-box" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results